Deborah Andrews

Director (Audit Committee Chair) at BioTime - , California, United States

Deborah Andrews's Colleagues at BioTime
Jennifer Bahr-Davidson

Sr. Director, Technical Operations and Quality Assurance

Contact Jennifer Bahr-Davidson

Hal Sternberg

VP Reasearch/Member Office of President

Contact Hal Sternberg

Gary Hogge

SVP, Clinical and Medical Affairs

Contact Gary Hogge

View All Deborah Andrews's Colleagues
Deborah Andrews's Contact Details
HQ
Location
Monrovia,California,United States
Company
BioTime
Deborah Andrews's Company Details
BioTime logo, BioTime contact details

BioTime

, California, United States • 51 - 200 Employees
Biotechnology

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage's programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage's clinical assets include (i) OpRegen®, a retinal pigment epithelium transplant therapy in Phase I/IIa development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase I/IIa development for the treatment of acute spinal cord injuries; and (iii) VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells currently in Phase I development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com.

Details about BioTime
Frequently Asked Questions about Deborah Andrews
Deborah Andrews currently works for Lineage Cell Therapeutics.
Deborah Andrews's role at Lineage Cell Therapeutics is Director (Audit Committee Chair).
Deborah Andrews's email address is ***@biotimeinc.com. To view Deborah Andrews's full email address, please signup to ConnectPlex.
Deborah Andrews works in the Research industry.
Deborah Andrews's colleagues at BioTime are Jie Li, Renevia Trial, Jennifer Bahr-Davidson, Nina Orike, Hal Sternberg, Floyd Kastning, Gary Hogge and others.
Deborah Andrews's phone number is
See more information about Deborah Andrews